ಡೆಲ್ಟಾ ರೂಪಾಂತರ ವಿರುದ್ಧವೂ ಕೊವ್ಯಾಕ್ಸಿನ್ ಪರಿಣಾಮಕಾರಿ: ಅಂತಿಮ ವರದಿ

Efficacy analysis demonstrates Covaxin to be 93.4% effective against severe symptomatic COVID19. Efficacy data demonstrates 65.2% protection against the SARS-CoV-2, B.1.617.2 Delta variant: Bharat Biotech

— ANI (@ANI) July 3, 2021